当前位置: 首页 >> 检索结果
7510. The Effect of Erythropoietin-Stimulating Agents on Health-Related Quality of Life in Anemia of Chronic Kidney Disease: A Systematic Review and Meta-analysis.
作者: David Collister.;Paul Komenda.;Brett Hiebert.;Ravindi Gunasekara.;Yang Xu.;Fredrick Eng.;Blake Lerner.;Kerry Macdonald.;Claudio Rigatto.;Navdeep Tangri.
来源: Ann Intern Med. 2016年164卷7期472-8页
The efficacy of erythropoietin-stimulating agents (ESAs) for improving health-related quality of life (HRQOL) in anemia of chronic kidney disease (CKD) is unclear.
7512. Framing Financial Incentives to Increase Physical Activity Among Overweight and Obese Adults: A Randomized, Controlled Trial.
作者: Mitesh S Patel.;David A Asch.;Roy Rosin.;Dylan S Small.;Scarlett L Bellamy.;Jack Heuer.;Susan Sproat.;Chris Hyson.;Nancy Haff.;Samantha M Lee.;Lisa Wesby.;Karen Hoffer.;David Shuttleworth.;Devon H Taylor.;Victoria Hilbert.;Jingsan Zhu.;Lin Yang.;Xingmei Wang.;Kevin G Volpp.
来源: Ann Intern Med. 2016年164卷6期385-94页
Financial incentive designs to increase physical activity have not been well-examined.
7515. Screening for Depression in Children and Adolescents: U.S. Preventive Services Task Force Recommendation Statement.
Update of the 2009 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for major depressive disorder (MDD) in children and adolescents.
7516. Nonpharmacologic Versus Pharmacologic Treatment of Adult Patients With Major Depressive Disorder: A Clinical Practice Guideline From the American College of Physicians.
The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the comparative effectiveness of treatment with second-generation antidepressants versus nonpharmacologic treatments for major depressive disorder in adults.
7517. Screening for Major Depressive Disorder in Children and Adolescents: A Systematic Review for the U.S. Preventive Services Task Force.
作者: Valerie Forman-Hoffman.;Emily McClure.;Joni McKeeman.;Charles T Wood.;Jennifer Cook Middleton.;Asheley C Skinner.;Eliana M Perrin.;Meera Viswanathan.
来源: Ann Intern Med. 2016年164卷5期342-9页
Major depressive disorder (MDD) is common among children and adolescents and is associated with functional impairment and suicide.
7518. Comparative Benefits and Harms of Antidepressant, Psychological, Complementary, and Exercise Treatments for Major Depression: An Evidence Report for a Clinical Practice Guideline From the American College of Physicians.
作者: Gerald Gartlehner.;Bradley N Gaynes.;Halle R Amick.;Gary N Asher.;Laura C Morgan.;Emmanuel Coker-Schwimmer.;Catherine Forneris.;Erin Boland.;Linda J Lux.;Susan Gaylord.;Carla Bann.;Christiane Barbara Pierl.;Kathleen N Lohr.
来源: Ann Intern Med. 2016年164卷5期331-41页
Primary care patients and clinicians may prefer options other than second-generation antidepressants for the treatment of major depressive disorder (MDD). The comparative benefits and harms of antidepressants and alternative treatments are unclear.
7519. Metabolically Healthy Obesity and Development of Chronic Kidney Disease: A Cohort Study.
作者: Yoosoo Chang.;Seungho Ryu.;Yuni Choi.;Yiyi Zhang.;Juhee Cho.;Min-Jung Kwon.;Young Youl Hyun.;Kyu-Beck Lee.;Hyang Kim.;Hyun-Suk Jung.;Kyung Eun Yun.;Jiin Ahn.;Sanjay Rampal.;Di Zhao.;Byung-Seong Suh.;Eun Cheol Chung.;Hocheol Shin.;Roberto Pastor-Barriuso.;Eliseo Guallar.
来源: Ann Intern Med. 2016年164卷5期305-12页
The risk for chronic kidney disease (CKD) among obese persons without obesity-related metabolic abnormalities, called metabolically healthy obesity, is largely unexplored.
|